語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Oncological PET/CT with histological...
~
Cerci, Juliano.
Oncological PET/CT with histological confirmation[electronic resource] /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.07575
書名/作者:
Oncological PET/CT with histological confirmation/ edited by Juliano Cerci, Stefano Fanti, Dominique Delbeke.
其他作者:
Cerci, Juliano.
出版者:
Cham : : Springer International Publishing :, 2016.
面頁冊數:
vii, 97 p. : : ill., digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Tomography, Emission.
標題:
Histology, Pathological.
標題:
Medicine.
標題:
Nuclear medicine.
標題:
Oncology.
標題:
Pathology.
標題:
Medicine & Public Health.
標題:
Nuclear Medicine.
ISBN:
9783319278803
ISBN:
9783319278780
內容註:
PART I. Biopsy guided PET/CT: Principle of biopsy guided imaging -- FDG PET/CT to guide biopsy: methods -- FDG PET/CT to guide biopsy: type of acess -- PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma -- FDG PET/CT to guide biopsy in lymphoma: results -- PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions -- FDG PET/CT to guide biopsy in pancreatic lesions: results -- PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions -- FDG PEM to guide biopsy in breast lesions: results -- PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies -- FDG PET/CT to guide biopsy in CNS: results -- PART VI. PET/CT and prostate cancer -- Choline PET/CT to guide biopsy in prostate cancer diagnosis -- PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results.
摘要、提要註:
This book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book.
電子資源:
http://dx.doi.org/10.1007/978-3-319-27880-3
Oncological PET/CT with histological confirmation[electronic resource] /
Oncological PET/CT with histological confirmation
[electronic resource] /edited by Juliano Cerci, Stefano Fanti, Dominique Delbeke. - Cham :Springer International Publishing :2016. - vii, 97 p. :ill., digital ;24 cm.
PART I. Biopsy guided PET/CT: Principle of biopsy guided imaging -- FDG PET/CT to guide biopsy: methods -- FDG PET/CT to guide biopsy: type of acess -- PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma -- FDG PET/CT to guide biopsy in lymphoma: results -- PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions -- FDG PET/CT to guide biopsy in pancreatic lesions: results -- PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions -- FDG PEM to guide biopsy in breast lesions: results -- PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies -- FDG PET/CT to guide biopsy in CNS: results -- PART VI. PET/CT and prostate cancer -- Choline PET/CT to guide biopsy in prostate cancer diagnosis -- PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results.
This book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book.
ISBN: 9783319278803
Standard No.: 10.1007/978-3-319-27880-3doiSubjects--Topical Terms:
406083
Tomography, Emission.
LC Class. No.: RC78.7.T62
Dewey Class. No.: 616.07575
Oncological PET/CT with histological confirmation[electronic resource] /
LDR
:02539nam a2200313 a 4500
001
446884
003
DE-He213
005
20160923132224.0
006
m d
007
cr nn 008maaau
008
161201s2016 gw s 0 eng d
020
$a
9783319278803
$q
(electronic bk.)
020
$a
9783319278780
$q
(paper)
024
7
$a
10.1007/978-3-319-27880-3
$2
doi
035
$a
978-3-319-27880-3
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC78.7.T62
072
7
$a
MMN
$2
bicssc
072
7
$a
MED080000
$2
bisacsh
082
0 4
$a
616.07575
$2
23
090
$a
RC78.7.T62
$b
O58 2016
245
0 0
$a
Oncological PET/CT with histological confirmation
$h
[electronic resource] /
$c
edited by Juliano Cerci, Stefano Fanti, Dominique Delbeke.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
vii, 97 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
PART I. Biopsy guided PET/CT: Principle of biopsy guided imaging -- FDG PET/CT to guide biopsy: methods -- FDG PET/CT to guide biopsy: type of acess -- PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma -- FDG PET/CT to guide biopsy in lymphoma: results -- PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions -- FDG PET/CT to guide biopsy in pancreatic lesions: results -- PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions -- FDG PEM to guide biopsy in breast lesions: results -- PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies -- FDG PET/CT to guide biopsy in CNS: results -- PART VI. PET/CT and prostate cancer -- Choline PET/CT to guide biopsy in prostate cancer diagnosis -- PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results.
520
$a
This book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book.
650
0
$a
Tomography, Emission.
$3
406083
650
0
$a
Histology, Pathological.
$3
402457
650
0
$a
Medicine.
$3
373206
650
0
$a
Nuclear medicine.
$3
338843
650
0
$a
Oncology.
$3
205017
650
0
$a
Pathology.
$3
340546
650
1 4
$a
Medicine & Public Health.
$3
463493
650
2 4
$a
Nuclear Medicine.
$3
464181
700
1
$a
Cerci, Juliano.
$3
639941
700
1
$a
Fanti, Stefano.
$3
468557
700
1
$a
Delbeke, Dominique.
$3
639942
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-27880-3
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-319-27880-3
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入